Description

Abstract:

Dr. Teague is an Assistant Professor of Radiology, Department of Radiology, Indiana University School of Medicine, Indianapolis, IN. Dr. Rosenblum is Vice Chair, Department of Radiology, and Director, Interventional Radiology, MetroHealth Medical Center, and Assistant Professor of Radiology, Case Western Reserve University, Cleveland, OH. Dr. Olszewski is a Research Scientist, Ms. Dharaiya is a Research Scientist, and Mr. Popilock is a Product Manager, Computed Tomography Clinical Science, Philips Healthcare, Cleveland, OH.

The evolution of multidetector computed tomography (MDCT) throughout the past decade has established its position as the workhorse of radiology. In addition to facilitating faster and improved diagnoses in the routine examinations—such as thoracic, abdominal, pelvic, brain, neck, and spine— that make up >85% of annual CT exams,1 this evolution has sparked a surge in vascular imaging procedures, such as CT angiography (CTA).

Diagnostic image quality in CT angiography can be achieved using lower effective contrast volumes with the latest CT technology that optimizes speed, power, coverage, and dose management. Operating cost benefits are realized through a reduction in per-patient contrast volumes, while patients benefit from a reduced risk of contrast-induced nephropathy and lower lifetime medical radiation exposure.